Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus - van der Meer, R W; Rijzewijk, L J; de Jong, H W (Circulation, 2009)
et al.